RecruitingNCT06184971
Biliary Atresia Research Network Northeast
Biliary Atresia Research Network Northeast (BARNN)
Sponsor
Yale University
Enrollment
150 participants
Start Date
May 6, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This is a multi-center retrospective chart review to compile a data repository of the management and outcomes of children with biliary atresia. Overall, investigators aim to evaluate which specific factors contribute to improved patient outcomes, to help guide potential improvements in patient care and resource utilization.
Eligibility
Max Age: 12 Years
Inclusion Criteria8
- Children with a healthcare encounter related to biliary atresia at a participating institution during the study period (January 1st, 2012 through December 31st, 2021)
- Age 12 years and younger at the time of the qualifying encounter during the study period (encompassing patients born between January 2nd, 1999 through December 31st, 2021)
- Diagnosis of biliary atresia, based on one of the following ICD-10 codes:
- Q44.2 Atresia of bile ducts
- Q44.3 Congenital stenosis and stricture of bile ducts
- Q44.4 Disorders of the biliary tract with major complication or comorbidity
- Q44.5 Other congenital malformations of the bile ducts
- Q44.6 Disorders of the biliary tract without major complication or comorbidity
Exclusion Criteria4
- Patients aged 13 years old or older during the study period (i.e. those born before January 2nd, 1999)
- Patients born and/or diagnosed with biliary atresia after the end of the study period (i.e. those born after December 31st, 2021)
- No diagnosis of biliary atresia
- History of biliary atresia without any episodes of care related to biliary atresia during the study period (e.g. a teenager with history of BA who underwent Kasai procedure as an infant and has no current issues related to their BA and is receiving care for an unrelated reason)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(14)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06184971
Related Trials
High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
NCT050726261 location
Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
NCT058483101 location
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
NCT072508541 location
Nutritional Intervention for Biliary Atresia
NCT067640821 location
Biliary Atresia Study in Infants and Children
NCT0034555316 locations